Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -436 | 1,549 | 7,284 | 12,837 | -16,045 |
| Depreciation Amortization | 959 | 838 | 792 | 743 | 287 |
| Accounts receivable | -7,873 | -7,698 | -3,498 | -1,460 | -7,269 |
| Accounts payable and accrued liabilities | -537 | 89 | 669 | 1,426 | 1,388 |
| Other Working Capital | 16,943 | 16,891 | 19,654 | 23,867 | -6,778 |
| Other Operating Activity | 17,924 | 16,785 | 5,759 | 1,634 | 11,274 |
| Operating Cash Flow | $26,980 | $28,454 | $30,660 | $39,047 | $-17,143 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -13,000 | N/A | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | 4,997 |
| Common Stock Issued | 1,301 | 504 | 974 | 627 | 1,716 |
| Other Financing Activity | -1,916 | -1,907 | -1,849 | -1,759 | -75 |
| Financing Cash Flow | $-13,615 | $-1,403 | $-875 | $-1,132 | $6,638 |
| Beginning Cash Position | 13,269 | 13,269 | 13,269 | 13,269 | 23,774 |
| End Cash Position | 26,634 | 40,320 | 43,054 | 51,184 | 13,269 |
| Net Cash Flow | $13,365 | $27,051 | $29,785 | $37,915 | $-10,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | 26,980 | 28,454 | 30,660 | 39,047 | -17,143 |
| Free Cash Flow | 26,980 | 28,454 | 30,660 | 39,047 | -17,143 |